Mikhail M. Dikov

2.5k total citations
31 papers, 1.9k citations indexed

About

Mikhail M. Dikov is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Mikhail M. Dikov has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Immunology. Recurrent topics in Mikhail M. Dikov's work include Adenosine and Purinergic Signaling (8 papers), Cancer Cells and Metastasis (6 papers) and Ion Transport and Channel Regulation (5 papers). Mikhail M. Dikov is often cited by papers focused on Adenosine and Purinergic Signaling (8 papers), Cancer Cells and Metastasis (6 papers) and Ion Transport and Channel Regulation (5 papers). Mikhail M. Dikov collaborates with scholars based in United States, South Korea and Japan. Mikhail M. Dikov's co-authors include David P. Carbone, Sergey V. Novitskiy, Sergey Ryzhov, Italo Biaggioni, Igor Feoktistov, Anna E. Goldstein, Yuhui Huang, Michael R. Blackburn, Rinat Zaynagetdinov and Elena E. Tchekneva and has published in prestigious journals such as Blood, The Journal of Immunology and Gastroenterology.

In The Last Decade

Mikhail M. Dikov

31 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mikhail M. Dikov United States	20	868	683	604	485	240	31	1.9k
Michael K.K. Wong United States	15	931 1.1×	553 0.8×	567 0.9×	524 1.1×	391 1.6×	25	2.1k
Amanda Littlewood‐Evans Switzerland	24	1.4k 1.6×	583 0.9×	407 0.7×	91 0.2×	294 1.2×	30	2.4k
Robert D. Leone United States	15	1.1k 1.3×	839 1.2×	690 1.1×	322 0.7×	722 3.0×	34	2.5k
Simona Romano Italy	28	1.3k 1.5×	434 0.6×	528 0.9×	44 0.1×	259 1.1×	89	2.2k
Lucillia Bezu France	19	524 0.6×	833 1.2×	625 1.0×	147 0.3×	106 0.4×	42	1.7k
Gerhard Breipohl Germany	21	1.5k 1.7×	358 0.5×	260 0.4×	138 0.3×	79 0.3×	44	2.8k
Danilo Marimpietri Italy	30	1.5k 1.7×	412 0.6×	578 1.0×	256 0.5×	459 1.9×	67	2.6k
Bertrand Allard Canada	24	1.0k 1.2×	1.7k 2.4×	1.8k 2.9×	1.8k 3.7×	343 1.4×	43	3.7k
Turid Hellevik Norway	19	524 0.6×	329 0.5×	631 1.0×	92 0.2×	267 1.1×	26	1.4k

Countries citing papers authored by Mikhail M. Dikov

Since Specialization

Citations

This map shows the geographic impact of Mikhail M. Dikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail M. Dikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail M. Dikov more than expected).

Fields of papers citing papers by Mikhail M. Dikov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail M. Dikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail M. Dikov. The network helps show where Mikhail M. Dikov may publish in the future.

Co-authorship network of co-authors of Mikhail M. Dikov

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail M. Dikov. A scholar is included among the top collaborators of Mikhail M. Dikov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail M. Dikov. Mikhail M. Dikov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suman, Shankar, Joseph M. Amann, Ruohan Wu, et al.. (2022). Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy. Neoplasia. 32. 100824–100824. 8 indexed citations

Shanker, Anil, et al.. (2020). Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings. Frontiers in Immunology. 11. 1958–1958. 17 indexed citations

Bill, Marius, Malith Karunasiri, Changxian Shen, et al.. (2019). EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia. Clinical Cancer Research. 26(3). 669–678. 20 indexed citations

Tchekneva, Elena E., Roman V. Uzhachenko, Michael J. Koenig, et al.. (2019). Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity. Journal for ImmunoTherapy of Cancer. 7(1). 95–95. 35 indexed citations

Carbone, David P., et al.. (2018). Abstract 2620: Aquaporin 11 as a new predictive biomarker of overall survival and platinum-based chemotherapy response in lung adenocarcinoma patients. Cancer Research. 78(13_Supplement). 2620–2620. 2 indexed citations

Bobko, Andrey A., Timothy D. Eubank, Benoît Driesschaert, et al.. (2017). Interstitial Inorganic Phosphate as a Tumor Microenvironment Marker for Tumor Progression. Scientific Reports. 7(1). 41233–41233. 83 indexed citations

Uzhachenko, Roman V., Kyungho Park, Anwari Akhter, et al.. (2015). Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy. Cancer Research. 75(22). 4728–4741. 46 indexed citations

Shanker, Anil, Mikhail M. Dikov, & David P. Carbone. (2015). Promise of Immunotherapy in Lung Cancer. Progress in tumor research. 42. 95–109. 2 indexed citations

Atochina‐Vasserman, Elena N., Asel Biktasova, Elena Abramova, et al.. (2013). Aquaporin 11 insufficiency modulates kidney susceptibility to oxidative stress. American Journal of Physiology-Renal Physiology. 304(10). F1295–F1307. 42 indexed citations

10.

Huang, Yuhui, Luping Lin, Anil Shanker, et al.. (2011). Resuscitating Cancer Immunosurveillance: Selective Stimulation of DLL1-Notch Signaling in T cells Rescues T-cell Function and Inhibits Tumor Growth. Cancer Research. 71(19). 6122–6131. 62 indexed citations

11.

Ryzhov, Sergey, Sergey V. Novitskiy, Anna E. Goldstein, et al.. (2011). Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells. The Journal of Immunology. 187(11). 6120–6129. 214 indexed citations

12.

Novitskiy, Sergey V., Ildiko Csiki, Yuhui Huang, et al.. (2010). Anti-Vascular Endothelial Growth Factor Treatment in Combination with Chemotherapy Delays Hematopoietic Recovery Due to Decreased Proliferation of Bone Marrow Hematopoietic Progenitor Cells. Journal of Thoracic Oncology. 5(9). 1410–1415. 16 indexed citations

13.

Tchekneva, Elena E., Zaza Khuchua, Linda Davis, et al.. (2008). Single Amino Acid Substitution in Aquaporin 11 Causes Renal Failure. Journal of the American Society of Nephrology. 19(10). 1955–1964. 40 indexed citations

14.

Ryzhov, Sergey, Sergey V. Novitskiy, David P. Carbone, et al.. (2008). Host A2B Adenosine Receptors Promote Carcinoma Growth. Neoplasia. 10(9). 987–995. 128 indexed citations

15.

Hartig, Sean M., et al.. (2008). Multifunctional Nanoparticulate Polyelectrolyte Complexes. Pharmaceutical Research. 25(8). 1963–1963. 99 indexed citations

16.

Dikov, Mikhail M., Joyce E. Ohm, Neelanjan Ray, et al.. (2005). Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation. The Journal of Immunology. 174(1). 215–222. 199 indexed citations

17.

Tikhomirov, Oleg, Mikhail M. Dikov, & Graham Carpenter. (2005). Identification of proteolytic fragments from ErbB-2 that induce apoptosis. Oncogene. 24(24). 3906–3913. 9 indexed citations

18.

Lee, Choon-Taek, Kyungho Park, Kiyoshi Yanagisawa, et al.. (2004). Combination Therapy with Conditionally Replicating Adenovirus and Replication Defective Adenovirus. Cancer Research. 64(18). 6660–6665. 41 indexed citations

19.

Lee, Choon‐Taek, Ki Hun Park, Yasushi Adachi, et al.. (2002). Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer. Cancer Gene Therapy. 10(1). 57–63. 62 indexed citations

20.

Adachi, Yasushi, Choon‐Taek Lee, Keith Coffee, et al.. (2002). Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology. 123(4). 1191–1204. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact